-Live Mint The judgement whittles down an already embattled freedom available to the Press In an important judgement it delivered on Tuesday, the Supreme Court has institutionalized the power to temporarily prohibit the Press from reporting court proceedings in case it interferes with the right to a free and fair trial. While the court shied from prescribing guidelines for the Press on court reporting, in the same breath it allowed individuals and companies...
More »SEARCH RESULT
Don’t compromise open justice
-The Hindu We live in a legal Environment where the rule of sub judice is regarded as an anachronism, emanating from a time when all trials were decided by jurors susceptible to influence by what was published in the press. By and large, the law of sub judice, which regulates the dissemination of matter under the consideration of the court, is a dead letter. In such a context, the Supreme Court’s...
More »Delhi government may impose blanket ban on plastic bags-Ambika Pandit & Neha Lalchandani
-The Economic Times After one failed attempt in 2009, the Delhi government is making yet another effort to make plastic bags history in Delhi. This time the proposed blanket ban comes with zero tolerance to even plastic used to cover school books, magazines and invitation cards. These are some of the provisions of a proposal of the Environment department for imposing a ban on not just sale and use but even...
More »Plea for stalling Kudankulam nuclear power project reaches SC
-PTI The row over setting up the Kudankulam nuclear power plant in Tamil Nadu reached the Supreme Court on Monday with a petition, which sought its directions to restrain the Union government and other authorities from commissioning the controversial project. The Special Leave Petition (SLP) by social activist G Sundarrajan against the Madras high court's August 31 decision refusing to impose any restraint has claimed that non-implementation of various recommendations formulated by...
More »Dengue still retains its deadly bite -R Prasad
-The Hindu Vaccine’s overall efficacy in a recent trial is ‘lower than expected’ The just concluded Phase IIb (proof-of-concept) dengue vaccine trial against all the four virus types (serotypes) that cause dengue has not only shown an unexpectedly low efficacy of 30.2 per cent but has also challenged many well-established hypotheses and ideas. The trial was conducted in about 4,000 children in the age group 4 and 11 in the dengue endemic district...
More »